Lab-Grown eye cells implanted to fight blindness
NCT ID NCT07418177
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage trial tests whether transplanting lab-grown retinal cells (made from stem cells) into the eye is safe for people with late-stage age-related macular degeneration. Nine participants will receive the cell transplant and be monitored for side effects and any improvement in vision. The goal is to see if this approach can stop or slow further vision loss.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AMD - AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital with Nanjing Medical University
Nanjing, Jiangsu, 210029, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Vision training may lift mood in macular degeneration patients
- Could a light beam slow vision loss? new trial tests laser therapy for AMD
- Eye bleeding study aims to predict who sees better after gas procedure
- Can red light slow vision loss in dry AMD?
- New pill for macular degeneration enters first human tests